| Fonds | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 301.097.998 $ | +47.123.522 $ | +17,6 % | 1.074.691.719 $ | -165.651.533 $ | -10,9 % | 1.511.990.283 $ | +335.566.021 $ | +29,4 % | 995.595.375 $ | +299.315.160 $ | +44,3 % | |
| FMR LLC | 357.226.003 $ | -75.576.129 $ | -17,5 % | 432.802.132 $ | +106.686.826 $ | +32,7 % | 326.115.306 $ | +154.222.504 $ | +89,7 % | |||
| BlackRock, Inc. | 180.502.133 $ | +35.113.378 $ | +24,2 % | 145.388.755 $ | -35.267.406 $ | -19,5 % | 180.656.161 $ | +47.221.940 $ | +35,4 % | 133.434.221 $ | +25.140.182 $ | +23,2 % |
| RA CAPITAL MANAGEMENT, L.P. | 156.667.131 $ | -257.511 $ | -0,2 % | 156.924.642 $ | +52.709.478 $ | +50,6 % | 104.215.164 $ | +20.691.630 $ | +24,8 % | |||
| Atlas Venture Life Science Advisors, LLC | 96.797.168 $ | -23.419.646 $ | -19,5 % | 120.216.814 $ | -21.367.317 $ | -15,1 % | 141.584.131 $ | +15.303.341 $ | +12,1 % | |||
| VANGUARD GROUP INC | 140.371.470 $ | +44.683.732 $ | +46,7 % | 95.687.738 $ | +21.716.600 $ | +29,4 % | ||||||
| PRICE T ROWE ASSOCIATES INC /MD/ | 99.067.000 $ | -35.772.000 $ | -26,5 % | 134.839.000 $ | +47.188.000 $ | +53,8 % | ||||||
| JPMORGAN CHASE & CO | 125.557.326 $ | +26.056.838 $ | +26,2 % | 99.500.488 $ | +54.822.585 $ | +122,7 % | ||||||
| STATE STREET CORP | 120.595.865 $ | +12.010.144 $ | +11,1 % | 108.585.721 $ | +14.247.356 $ | +15,1 % | ||||||
| WELLINGTON MANAGEMENT GROUP LLP | 110.959.941 $ | -9.606.197 $ | -8,0 % | 120.566.138 $ | +27.388.251 $ | +29,4 % | ||||||
| Frazier Life Sciences Management, L.P. | 100.056.600 $ | +4.998.273 $ | +5,3 % | 95.058.327 $ | +7.418.318 $ | +8,5 % | ||||||
| 301.097.998 $ | +47.123.522 $ | +17,6 % | 1.074.691.719 $ | -165.651.533 $ | -10,9 % | 1.511.990.283 $ | +335.566.021 $ | +29,4 % | 995.595.375 $ | +299.315.160 $ | +44,3 % | |